Cyclerion Therapeutics Inc Earnings

The next earnings date for Cyclerion Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Cyclerion Therapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Cyclerion Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/12/2025---$-0.11---
05/05/2025After Market$-0.56---
03/03/2025After Market------
11/11/2024After Market$-0.29---
08/07/2024Before Market$-0.53---
05/07/2024After Market$-0.62---
03/05/2024After Market$-0.68---
11/13/2023After Market$3.11---
07/28/2023After Market$-1.83-554.36%
05/12/2023Before Market$-3.20-965.23%
03/22/2023After Market$-0.1741.38%
11/03/2022After Market$-0.2422.58%
08/09/2022After Market$-0.31-3.33%
05/04/2022After Market$-0.3016.67%
02/24/2022After Market$-0.33-10.00%
11/09/2021After Market$-0.2625.71%
07/29/2021After Market$-0.45---
04/30/2021After Market$-0.39---
02/25/2021Before Market$-0.54-184.21%
11/05/2020Before Market$-0.68-21.43%
08/03/2020Before Market$-0.7018.60%
05/04/2020After Market$-0.7316.09%
03/12/2020After Market$-0.95-6.74%
11/12/2019After Market$-123.08%
08/12/2019Before Market$-1.18-40.48%
05/13/2019Before Market$-0.92---
01/28/2019---$-1.62---
10/09/2018---$-3.54---

More About Cyclerion Therapeutics Inc

Country
USA
Full Time Employees
1

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Cyclerion Therapeutics Inc Earnings” Can Refer to the Cyclerion Therapeutics Inc Earnings Date

Some people say “Cyclerion Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Cyclerion Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Cyclerion Therapeutics Inc Stock on the Earnings Date

If you own Cyclerion Therapeutics Inc stock (CYCN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Cyclerion Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Cyclerion Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Cyclerion Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Cyclerion Therapeutics Inc earnings or anything else related to the stock market.